FDA and big pharma cannot and wont ignore the 60% changes.
Once these two parties form a threesome with MSB we are adding $20 a share in value all the while being loved by the insurance companies and patients.
Don't be too hard on the sheep - this announcement a bit harder than average to see the value. It will have to be spelt out to them over time by big pharma joining in then the FDA approving.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-378
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |